5th Immune Effector Cell Therapies in Multiple Myeloma Workshop

March 23 - 24, 2024 - Boston Marriott Long Wharf, Boston, MA

IMS is pleased to announce that the 5th Annual Immune Effector Cell Therapies in Multiple Myeloma Workshop will take place from March 23-24, 2024 in Boston, MA.

Tentative Agenda

Our sponsors:
Titanium
Platinum
Gold
Silver

Building upon the success of prior workshops, the International Myeloma Society is happy to host the 5th Immune Effector Cell Therapies in Multiple Myeloma Workshop to discuss immune-based therapies in myeloma including the latest CAR T cell and bispecific T cell-engager clinical data, promising preclinical leads, updated correlative analyses exploring predictors of response and resistance mechanisms, and next-generation manufacturing and CAR construct approaches, including “off-the-shelf” allogeneic and NK-cell based strategies.

Registration Fees

In person On Demand
Members $550 0
Non-members $700 $200
Trainees $200 $50
Allied Health Professionals $250 $125
Industry $850 $250

 

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Stay updated on our Events